|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Relmada Therapeutics (NASDAQ: RLMD) through any online brokerage.
The latest price target for Relmada Therapeutics (NASDAQ: RLMD) was reported by Goldman Sachs on October 28, 2020. The analyst firm set a price target for 40.00 expecting RLMD to rise to within 12 months (a possible 26.02% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $31.74 last updated Today at 4:04:16 PM.
There are no upcoming dividends for Relmada Therapeutics.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.